Company

Phlox Therapeutics BV

Phlox Therapeutics develops RNA-based gene therapies for genetic heart diseases.

About

Founded in 2022, Phlox Therapeutics develops RNA-based therapies for genetic heart diseases, including cardiomyopathies. It is based in North Holland, Netherlands. In November 2024, it raised EUR 1.9 million in seed funding from ROM Utrecht Region, including Utrecht Holdings, BioGeneration Ventures, and AMC Ventures Holding.

3Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in